Safety of Oral Vancomycin in Functionally Anephric Patients
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (≤0.66 μg/ml) serum levels in two of the five volunteers.
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1978
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352521/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/718158/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.4.634 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|